This episode offers a detailed look into the FDA’s recent PCAC meeting and what the future of peptide compounding could lead to for pharmacy professionals.
News|Articles|July 24, 2006
Health begins at home
Armed with a plethora of OTC test kits, consumers are taking do-it-yourself screenings to new heights
Advertisement
Advertisement
Related to this article
Eli Lilly’s new indication helps improve medication delivery for adults with type 2 diabetes, reducing annual injections by over 300.
The update adds efficacy and safety data on adults newly diagnosed with pulmonary arterial hypertension.
The approval is the first new treatment advance in more than 30 years for chronic kidney disease for adults with type 1 diabetes.
Advertisement
Advertisement
Trending on Drug Topics
1
Polypharmacy, Drug Interactions Threaten Older Adults’ Medication Safety
2
Muscle Preservation Is Key in GLP-1 Therapy for Postmenopausal Women
3
Tozorakimab Reduces COPD Exacerbations in Phase 3 Trials
4
Injectable HIV Treatment Beats Daily Pills in Adolescent Trial
5